OncoMatch/Clinical Trials/NCT07776262
Safety and Efficacy of Cryoablation for Thyroid Tumors
Is NCT07776262 recruiting? Yes, currently enrolling (Sep 2026). This NA trial studies non-drug interventions for thyroid tumor.
The goal of this clinical study is to learn if cryoablation works to treat thyroid tumors. It will also learn about the safety of cryoablation for thyroid tumors. The main questions it aims to answer are: * Does cryoablation shrink thyroid tumors over time? * What side effects or problems do participants have after cryoablation? Participants will receive cryoablation treatment guided by ultrasound. Researchers will track tumor size changes and check for any safety issues during follow-up visits.
Check if I qualifyExtracted eligibility criteria
Cancer type
Thyroid Gland Carcinoma
Prior therapy
Cannot have received: thyroid surgery
Cannot have received: radiation therapy
Lab requirements
Blood counts
Severe coagulation dysfunction, or patients taking oral anticoagulants who have not reached the required drug-withdrawal period
Severe coagulation dysfunction, or patients taking oral anticoagulants who have not reached the required drug-withdrawal period
Structured fields extracted by AI. May contain errors — verify against the official protocol.
Frequently asked questions
Is NCT07776262 currently recruiting?
Yes, this trial is currently recruiting patients.
Are there prior therapy exclusions?
Yes. Prior thyroid surgery, radiation therapy disqualifies patients from enrollment.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualifyRelated pages